Skip to main content
placeholder image

Preliminary Azd9291 Western and Asian Clinical Pharmacokinetics (Pk) in Patients (Pts) and Healthy Volunteers (Hv): Implications for Formulation, Dose and Dosing Frequency in Pivotal Clinical Studies

Journal Article


Abstract


Publication Date


  • 2014

Citation


  • Planchard, D., Dickinson, P. A., Brown, K. H., Kim, D., Kim, S., Ohe, Y., . . . Ranson, M. (2014). Preliminary Azd9291 Western and Asian Clinical Pharmacokinetics (Pk) in Patients (Pts) and Healthy Volunteers (Hv): Implications for Formulation, Dose and Dosing Frequency in Pivotal Clinical Studies. Annals of Oncology, 25, iv154. doi:10.1093/annonc/mdu331.24

Web Of Science Accession Number


Start Page


  • iv154

Volume


  • 25

Abstract


Publication Date


  • 2014

Citation


  • Planchard, D., Dickinson, P. A., Brown, K. H., Kim, D., Kim, S., Ohe, Y., . . . Ranson, M. (2014). Preliminary Azd9291 Western and Asian Clinical Pharmacokinetics (Pk) in Patients (Pts) and Healthy Volunteers (Hv): Implications for Formulation, Dose and Dosing Frequency in Pivotal Clinical Studies. Annals of Oncology, 25, iv154. doi:10.1093/annonc/mdu331.24

Web Of Science Accession Number


Start Page


  • iv154

Volume


  • 25